All human papillomavirus articles
-
News
HPV vaccination switch to 1-dose gender-neutral approach
Canadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and eliminate cervical cancer, suggests new modelling.
-
News
Call for global gender-neutral HPV vaccination by 2030
A new global initiative is calling for a more ambitious, ethical and equitable approach that will see more boys and men gain access to cancer-preventing Human Papillomavirus (HPV) vaccination and protect more people worldwide from HPV-related cancers.
-
Features
Infection, immunity and the One Health response in Indonesia
Infectious diseases (IDs) are a major health issue in Indonesia, as in many tropical low- and middle-income countries (LMICs), placing a significant economic burden on limited resources. Vaccination may have a critical role to play in the prevention of zoonotic infectious diseases.
-
News
HPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows
The human papillomavirus, or HPV, vaccine is cutting cases of cervical cancer right across the socio-economic spectrum, with most cases being prevented in more deprived groups, according to a major study funded by Cancer Research UK. Source: NIAID Colorized electron micrograph of HPV virus particles harvested and ...
-
News
$1.8M NIH grant will help researchers follow a virus on its path to the nucleus
Researchers have been awarded a $1.8 million grant to learn how human papillomavirus makes its way to a cell’s nucleus.
-
News
Researchers identify new genetic risk factors for persistent HPV infections
A new finding suggests that certain women may have a genetic susceptibility for persistent or frequent HPV infections, potentially raising their risk of getting cervical cancer from a high-risk HPV infection.
-
News
Study reveals how the immune system fights to keep herpes at bay
A recent study, conducted using lab-engineered cells, unveils the precise maneuvers used by host and herpes simplex virus (HSV) in the fight for dominance of the cell.